Current and historical daily PE Ratio for Tasly Pharmaceutical Group Co Ltd (
SHSE:600535
) from 2002 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Tasly Pharmaceutical Group stock (SHSE:600535) PE ratio as of Jun 08 2024 is 18.52.
More Details
Tasly Pharmaceutical Group Co Ltd (SHSE:600535) PE Ratio (TTM) Chart
Tasly Pharmaceutical Group Co Ltd (SHSE:600535) PE Ratio (TTM) Historical Data
View and export this data going back to 2002. Start your Free Trial
Total 1206
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Tasly Pharmaceutical Group PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-08 | 18.5 | 2024-04-05 | 21.9 |
| 2024-06-07 | 18.5 | 2024-04-03 | 21.9 |
| 2024-06-06 | 18.4 | 2024-04-02 | 21.8 |
| 2024-06-05 | 18.7 | 2024-04-01 | 22.0 |
| 2024-06-04 | 18.7 | 2024-03-29 | 21.7 |
| 2024-06-03 | 18.5 | 2024-03-28 | 21.4 |
| 2024-05-31 | 18.8 | 2024-03-27 | 22.2 |
| 2024-05-30 | 18.5 | 2024-03-26 | 22.4 |
| 2024-05-29 | 18.7 | 2024-03-25 | 22.4 |
| 2024-05-28 | 19.1 | 2024-03-22 | 22.8 |
| 2024-05-27 | 19.3 | 2024-03-21 | 23.2 |
| 2024-05-24 | 19.4 | 2024-03-20 | 23.7 |
| 2024-05-23 | 19.4 | 2024-03-19 | 23.9 |
| 2024-05-22 | 19.6 | 2024-03-18 | 24.3 |
| 2024-05-21 | 20.0 | 2024-03-15 | 23.7 |
| 2024-05-20 | 20.4 | 2024-03-14 | 23.6 |
| 2024-05-17 | 20.4 | 2024-03-13 | 23.3 |
| 2024-05-16 | 20.4 | 2024-03-12 | 23.6 |
| 2024-05-15 | 20.9 | 2024-03-11 | 23.3 |
| 2024-05-14 | 21.5 | 2024-03-08 | 23.3 |
| 2024-05-13 | 21.1 | 2024-03-07 | 23.1 |
| 2024-05-10 | 21.3 | 2024-03-06 | 23.5 |
| 2024-05-09 | 21.4 | 2024-03-05 | 23.9 |
| 2024-05-08 | 21.4 | 2024-03-04 | 23.9 |
| 2024-05-07 | 21.5 | 2024-03-01 | 23.3 |
| 2024-05-06 | 21.5 | 2024-02-29 | 23.4 |
| 2024-05-03 | 20.9 | 2024-02-28 | 22.6 |
| 2024-05-02 | 20.9 | 2024-02-27 | 22.9 |
| 2024-04-30 | 20.9 | 2024-02-26 | 22.6 |
| 2024-04-29 | 20.8 | 2024-02-23 | 22.3 |
| 2024-04-26 | 20.7 | 2024-02-22 | 22.4 |
| 2024-04-25 | 20.1 | 2024-02-21 | 22.4 |
| 2024-04-24 | 20.1 | 2024-02-20 | 22.7 |
| 2024-04-23 | 20.4 | 2024-02-19 | 22.1 |
| 2024-04-22 | 20.6 | 2024-02-16 | 22.0 |
| 2024-04-19 | 20.7 | 2024-02-09 | 22.0 |
| 2024-04-18 | 20.8 | 2024-02-08 | 22.0 |
| 2024-04-17 | 20.5 | 2024-02-07 | 22.3 |
| 2024-04-16 | 20.1 | 2024-02-06 | 20.7 |
| 2024-04-15 | 21.1 | 2024-02-05 | 18.9 |
| 2024-04-12 | 20.8 | 2024-02-02 | 19.4 |
| 2024-04-11 | 21.1 | 2024-02-01 | 20.4 |
| 2024-04-10 | 21.2 | 2024-01-31 | 19.9 |
| 2024-04-09 | 21.5 | 2024-01-30 | 20.6 |
| 2024-04-08 | 21.2 | 2024-01-29 | 21.5 |
Tasly Pharmaceutical Group Co Ltd (SHSE:600535) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Tasly Pharmaceutical Group Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE000001C81
Share Class Description:
SHSE:600535: Class ACompare
Compare
Traded in other countries / regions
600535.China IPO Date
2002-08-23Description
Tasly Pharmaceutical Group Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. Its herbal medicines include Tasly Cerebral Care Granules and Tasly ICP. Its chemical medicines comprise of Ketotifen Fumarate Tablets, Thiamphenicol Capsules, Glucurolactone Tablets and Sulpiride Tablets. Some of the other products offered by the company include PharmceuticalSubstances & API, HerbalExtract, and Concentrated Herbal Granules.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers